Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Immune responses of patients on maintenance hemodialysis after infection by SARS-CoV-2: a prospective observational cohort study

Fig. 4

Baseline predictor of 28-day outcome. A ROC curve of MFI of HLA-DR on CD14-monocytes at the end of hemodialysis to predict WHO-CPS ≥ 6 at day 28. B Sensitivity, specificity, PPV and NPV of MFI < 44 HLA-DR on CD14-monocytes at the end of hemodialysis to predict WHO-CPS ≥ 6 at day 28. The OR could not be calculated because two values were zero. C ROC curve of the CD19-cell count at the end of hemodialysis to predict WHO-CPS ≤ 3 at day 28. D Sensitivity, specificity, PPV and NPV of CD19-cell count more than 40/mm3 at the end of hemodialysis to predict WHO-CPS ≤ 3 at day 28. The OR is provided. Abbreviations: AUC, area under the curve; CI, confidence interval; CPS, clinical performance scale; MFI, mean fluorescence intensity; n, number of patients; OR, odds ratio; NPV, negative predictive value; PPV, positive predictive value; ROC, receiver operator characteristics; WHO, World Health Organization

Back to article page